Categories: Wire Stories

KE Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 9, 2022 Eastern Time

BEIJING–(BUSINESS WIRE)–KE Holdings Inc. (�Beike” or the “Company”) (NYSE: BEKE), a leading integrated online and offline platform for housing transactions and services, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2021 after the U.S. market close on Wednesday, March 9, 2022.

The Company’s management will hold an earnings conference call at 8:00 P.M. Eastern Time on Wednesday, March 9, 2022 (9:00 A.M. Beijing Time on Thursday, March 10, 2022).

For participants who wish to join the call, please complete online registration using the link provided below at least 20 minutes prior to the scheduled call start time. Upon registration, participants will receive the conference call access information, including dial-in numbers, Direct Event passcode, a unique registrant ID and an e-mail with detailed instructions to join the conference call.

Participant Online Registration: http://apac.directeventreg.com/registration/event/5109289

A replay of the conference call will be accessible through March 16, 2022, by dialing the following numbers:

United States Toll Free:

+1-855-452-5696

Mainland, China:

400-602-2065

Hong Kong, China:

+852-3051-2780

International:

+61-2-8199-0299

Conference ID:

5109289

A live and archived webcast of the conference call will also be available at the Company’s investor relations website at https://investors.ke.com

About KE Holdings Inc.

KE Holdings Inc. is a leading integrated online and offline platform for housing transactions and services. The Company is a pioneer in building the industry infrastructure and standards in China to reinvent how service providers and housing customers efficiently navigate and consummate housing transactions, ranging from existing and new home sales, home rentals, to home renovation, real estate financial solutions, and other services. The Company owns and operates Lianjia, China’s leading real estate brokerage brand and an integral part of its Beike platform. With more than 20 years of operating experience through Lianjia since its inception in 2001, the Company believes the success and proven track record of Lianjia pave the way for it to build the industry infrastructure and standards and drive the rapid and sustainable growth of Beike.

For more information, please visit: https://investors.ke.com

Contacts

For investor and media inquiries:

KE Holdings Inc.

Investor Relations

Matthew Zhao

Siting Li

E-mail: ir@ke.com

The Piacente Group, Inc.

Yang Song

Tel: +86-10-6508-0677

E-mail: ke@tpg-ir.com

In the United States:

The Piacente Group, Inc.

Brandi Piacente

Tel: +1-212-481-2050

E-mail: ke@tpg-ir.com

Alex

Recent Posts

Most of the world is living under eroding democratic accountability

The world's 12 most populous countries saw declines in a global index measuring democratic accountability.…

11 mins ago

Graphisoft Takes Center Stage as Title Sponsor at Singapore Archifest 2024, Showcasing Innovation and Leadership in Architecture

Singapore and regional Industry professionals can anticipate Graphisoft’s latest BIM product innovations, including BIMx on…

56 mins ago

Discovery Taiwan And MediaTek Collaborate On New Short Documen-tary, CHASING BREAKTHROUGH

SINGAPORE - Media OutReach Newswire - 16 May 2024 - Discovery Taiwan and MediaTek have…

1 hour ago

Leading Hong Kong Law Firm Oldham, Li & Nie Pioneers Elder Law Practice to Serve the Community

HONG KONG SAR - Media OutReach Newswire - 16 May 2024 - Oldham, Li &…

1 hour ago

Cyber Attack-Data Breach is Top Business Risk Facing Financial Institutions, Aon Survey

HONG KONG SAR - Media OutReach Newswire - 16 May 2024 - Aon plc (NYSE:…

1 hour ago

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment…

3 hours ago